Literature DB >> 23134505

Premorbid body mass index and risk of amyotrophic lateral sclerosis.

Éilis J O'Reilly1, Hao Wang, Marc G Weisskopf, Kathryn C Fitzgerald, Guido Falcone, Marjorie L McCullough, Michael Thun, Yikyung Park, Laurence N Kolonel, Alberto Ascherio.   

Abstract

Our objective was to determine if amyotrophic lateral sclerosis (ALS) risk varies according to body mass index (BMI) captured up to three decades earlier. At baseline 537,968 females and 562,942 males in five ongoing cohorts reported height, current weight and weight at age 18/21 years. During 14-28 years of follow-up, 1153 participants developed ALS. Cohort-specific Cox proportional hazards models were used to estimate rates that were then pooled with random-effects models. Results showed that lower BMI at baseline was associated with ALS; for each 5-unit increase in BMI, ALS rates were 21% lower (95% CI 14% 27%). Compared to individuals with healthy BMI, ALS rates were significantly lower among the overweight (RR = 0.76 (95% CI 0.62-0.93)) and obese (RR = 0.73 (95% CI 0.55-0.96)). Among never smokers the association persisted: RR = 0.75 (95% CI 0.65-0.85) for each 5-unit increase. Excluding the first seven years of follow-up, the associations were materially unchanged suggesting that weight loss from undiagnosed disease does not fully explain the findings. Overall, 75% of males and females had a healthy BMI at age 18/21 years, 15% of males and 8% of females were overweight or obese; there was no association with ALS although numbers with an unhealthy weight were small. In conclusion, these findings support an association between lower premorbid BMI and ALS.

Entities:  

Mesh:

Year:  2012        PMID: 23134505      PMCID: PMC3615420          DOI: 10.3109/21678421.2012.735240

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  30 in total

1.  Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis.

Authors:  W T Longstreth; L M Nelson; T D Koepsell; G van Belle
Journal:  Med Hypotheses       Date:  1991-02       Impact factor: 1.538

2.  Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study.

Authors:  W T Longstreth; V McGuire; T D Koepsell; Y Wang; G van Belle
Journal:  Arch Neurol       Date:  1998-02

3.  Prospective study of alcohol consumption and risk of coronary disease in men.

Authors:  E B Rimm; E L Giovannucci; W C Willett; G A Colditz; A Ascherio; B Rosner; M J Stampfer
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

4.  Nutritional status is a prognostic factor for survival in ALS patients.

Authors:  J C Desport; P M Preux; T C Truong; J M Vallat; D Sautereau; P Couratier
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 5.  Physical activity and the association with sporadic ALS.

Authors:  J H Veldink; S Kalmijn; G J Groeneveld; M J Titulaer; J H J Wokke; L H van den Berg
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

6.  The Nurses' Health Study: 20-year contribution to the understanding of health among women.

Authors:  G A Colditz; J E Manson; S E Hankinson
Journal:  J Womens Health       Date:  1997-02       Impact factor: 2.681

7.  Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study.

Authors:  Dexter Canoy; Nicholas Wareham; Robert Luben; Ailsa Welch; Sheila Bingham; Nicholas Day; Kay-Tee Khaw
Journal:  Obes Res       Date:  2005-08

8.  Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Authors:  Luc Dupuis; Hugues Oudart; Frédérique René; Jose-Luis Gonzalez de Aguilar; Jean-Philippe Loeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  Prospective study of cigarette smoking and amyotrophic lateral sclerosis.

Authors:  M G Weisskopf; M L McCullough; E E Calle; M J Thun; M Cudkowicz; A Ascherio
Journal:  Am J Epidemiol       Date:  2004-07-01       Impact factor: 4.897

10.  Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.

Authors:  E J Kasarskis; S Berryman; J G Vanderleest; A R Schneider; C J McClain
Journal:  Am J Clin Nutr       Date:  1996-01       Impact factor: 7.045

View more
  65 in total

1.  Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Ole Gredal; Murray A Mittleman; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-07-20       Impact factor: 4.092

2.  Antecedent Disease is Less Prevalent in Amyotrophic Lateral Sclerosis.

Authors:  Cassie S Mitchell; Sabrina K Hollinger; Shivani D Goswami; Meraida A Polak; Robert H Lee; Jonathan D Glass
Journal:  Neurodegener Dis       Date:  2015-02-20       Impact factor: 2.977

Review 3.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

4.  Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.

Authors:  Daniela Mariosa; John D Beard; David M Umbach; Rino Bellocco; Jean Keller; Tracy L Peters; Kelli D Allen; Weimin Ye; Dale P Sandler; Silke Schmidt; Fang Fang; Freya Kamel
Journal:  Am J Epidemiol       Date:  2017-03-01       Impact factor: 4.897

5.  Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies.

Authors:  Éilis J O'Reilly; Molin Wang; Hans-Olov Adami; Alvaro Alonso; Leslie Bernstein; Piet van den Brandt; Julie Buring; Sarah Daugherty; Dennis Deapen; D Michal Freedman; Dallas R English; Graham G Giles; Niclas Håkansson; Tobias Kurth; Catherine Schairer; Elisabete Weiderpass; Alicja Wolk; Stephanie A Smith-Warner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-04-16       Impact factor: 4.092

6.  Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.

Authors:  Johannes Dorst; Luc Dupuis; Susanne Petri; Katja Kollewe; Susanne Abdulla; Joachim Wolf; Markus Weber; David Czell; Christian Burkhardt; Frank Hanisch; Stefan Vielhaber; Thomas Meyer; Gabriele Frisch; Dagmar Kettemann; Torsten Grehl; Bertold Schrank; Albert C Ludolph
Journal:  J Neurol       Date:  2015-01-25       Impact factor: 4.849

7.  Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ran S Rotem; Ryan M Seals; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

Review 8.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

9.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

Review 10.  Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.

Authors:  Kaitlin A Hagan; Kassandra L Munger; Alberto Ascherio; Francine Grodstein
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.